Inspira Technologies Gains Major Approval for ART100 System Use
Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) is a trailblazer in life-support and diagnostic solutions. The company has recently gained a substantial milestone, as its INSPIRA™ ART100 system was approved for clinical validation by Israel’s largest healthcare provider. This development empowers healthcare professionals to utilize this innovative device during critical organ transplant procedures.
A leading team of physicians at a prominent medical center is set to evaluate the INSPIRA ART100 system's effectiveness in complex organ transplant scenarios. This hands-on experience with advanced technology aims to enhance the viability of organs through superior blood oxygenation methods. The unique capabilities of the INSPIRA ART100 allow it to provide out-of-body blood oxygenation, a crucial support during the transplant process, extending even to recovery phases.
Significance of Clinical Validation
This new phase indicates a pivotal application for the INSPIRA ART100 system, granting the company invaluable feedback from distinguished specialists in the field. As these experts assess the performance of the system in rigorous transplant situations, the insights gained will be instrumental for the ongoing development of Inspira’s flagship INSPIRA ART500 system. Designed to oxygenate blood effectively and support vital organs during critical respiratory failures, this system is expected to significantly advance respiratory care.
Inspira’s Growing Recognition
According to Dagi Ben-Noon, Chief Executive Officer of Inspira Technologies, the endorsement from such a reputable healthcare institution underscores the growing interest and acceptance of their technology both locally and internationally. This initiative solidifies Inspira's commitment to innovate and collaborate with healthcare professionals, striving to uncover new applications for their technologies.
Regulatory Clearances and System Overview
The INSPIRA ART100 system achieved FDA 510(k) clearance for cardiopulmonary bypass procedures in May 2024, accompanied by the Israeli AMAR certification for similar procedures in July 2024. The advanced hardware and software underpinning the system are foundational for the development of the INSPIRA ART500, which aims to meet the demands of modern respiratory therapy by allowing patients to be alert while their oxygen levels are stabilized—without relying on mechanical ventilation.
About Inspira Technologies
Inspira Technologies is on the forefront of developing cutting-edge respiratory support and diagnostic devices. The INSPIRA ART500 system, in particular, aims to transform critical care practices by facilitating patient awareness during treatments while effectively managing oxygen without mechanical support. The company also boasts the FDA-cleared INSPIRA ART100 that has garnered approvals for cardiopulmonary bypass procedures both domestically and internationally. Furthermore, their innovative HYLA blood sensor technology aims to redefine blood monitoring by eliminating the need for invasive blood draws. The pipeline also includes other promising products such as the Single-use patient kit, currently undergoing development.
Frequently Asked Questions
What is the INSPIRA ART100 system used for?
The INSPIRA ART100 system is designed to provide out-of-body blood oxygenation, primarily to support patients during organ transplant procedures.
Who approved the use of the INSPIRA ART100 system?
Israel's largest healthcare provider has approved the INSPIRA ART100 system for clinical validation and hands-on use in transplant scenarios.
What certifications does the INSPIRA ART100 hold?
The system has received FDA 510(k) clearance and Israeli AMAR certification for cardiopulmonary bypass and ECMO procedures.
How does Inspira Technologies contribute to medical innovation?
Inspira Technologies is developing advanced respiratory support technologies that enhance patient care, such as the INSPIRA ART500 and HYLA blood sensor.
How can I learn more about Inspira Technologies?
For additional information about Inspira Technologies and their products, visit their official website.
